Browse > Article

Effect of Relaxin Expressing Adenovirus for Rat Skin Flap Viability  

Yun, In-Sik (Institue for Human Tissue Restoration & Department of Plastic & Reconstructive Surgery Yonsei University College of Medicine)
Park, Yong-Sun (Institue for Human Tissue Restoration & Department of Plastic & Reconstructive Surgery Yonsei University College of Medicine)
Cheon, Young-Woo (Institue for Human Tissue Restoration & Department of Plastic & Reconstructive Surgery Yonsei University College of Medicine)
Jeon, Yeo-Reum (Institue for Human Tissue Restoration & Department of Plastic & Reconstructive Surgery Yonsei University College of Medicine)
Lee, Won-Jai (Institue for Human Tissue Restoration & Department of Plastic & Reconstructive Surgery Yonsei University College of Medicine)
Yun, Chae-Ok (Yonsei Cancer Research Center, Yonsei University College of Medicine)
Rah, Dong-Kyun (Institue for Human Tissue Restoration & Department of Plastic & Reconstructive Surgery Yonsei University College of Medicine)
Publication Information
Archives of Plastic Surgery / v.37, no.5, 2010 , pp. 519-525 More about this Journal
Abstract
Purpose: Of various effects of relaxin, we assumed that anti-fibrotic effects, neovascularization effects and vasodilatation effects of relaxin might enhance the survival rate of skin flap. In the current study, we used adenovirus expressing relaxin genes to examine whether these genes could enhance the survival rate of a skin flap. Methods: A total of 30 Sprangue-Dawley rats were divided into three groups: RLX group (10; relaxin virus injected group), CTR group (10; no gene coded virus injection group), and PBS group (10; PBS injected group). Each group was intradermally injected with the virus ($10^7$ PFU) and PBS 48 hours before and immediately before the flap elevation. A distally based flap $3{\times}9\;cm$ in size was elevated on the dorsal aspect of each rat. Following this, a flap was placed in the original location and then sutured using a #4-0 Nylon. A surviving area of the flap was measured and then compared on postoperative days 3, 7 and 10. Using a laser Doppler, the amount of blood flow was measured. On postoperative day 10, tissues were harvested for histologic examination and the number of blood vessels was counted. Results: There was a significant increase in the area of the flap survival in the RLX group on postoperative days 3 and 7. The Doppler measurement also showed significantly increased blood flow immediately after the operation and on postoperative days 7 and 10. The number of blood vessels was significantly greater in the RLX group in the tissue harvested on postoperative day 10. The VEGF concentration was significantly higher in the RLX group than others in the tissues harvested on postoperative day 10. Conclusion: Following an analysis of the effects of relaxin-secreting adenovirus on the survival of a flap, the surviving area of the flap and the blood flow also increased. A histopathology also showed an increase in the number of blood vessels and the concentration of VEGF.
Keywords
Relaxin; Adenovirus; Gene therapy; Angiogenesis; Flap;
Citations & Related Records
연도 인용수 순위
  • Reference
1 Seify H, Bilkay U, Jones G: Improvement of TRAM flap viability using human VEGF-induced angiogenesis: a comparative study of delay techniques. Plast Reconstr Surg 112: 1032, 2003   DOI   ScienceOn
2 Scalise A, Tucci MG, Lucarini G, Giantomassi F, Orlando F, Pierangeli M, Pugnaloni A, Bertani A, Ricotti G, Biagini G: Local rh-VEGF administration enhances skin flap survival more than other types of rh-VEGF administration: a clinical, morphological and immunohistochemical study. Exp Dermatol 13: 682, 2004   DOI   ScienceOn
3 Shima DT, Deutsch U, D'Amore PA: Hypoxic induction of vascular endothelial growth factor (VEGF) in human epithelial cells is mediated by increases in mRNA stability. FEBS Lett 370: 203, 1995   DOI   ScienceOn
4 Huang N, Khan A, Ashrafpour H, Neligan PC, Forrest CR, Kontos CD, Pang CY: Efficacy and mechanism of adeno-virus-mediated VEGF-165 gene therapy for augmentation of skin flap viability. Am J Physiol Heart Circ Physiol 291: H127, 2006   DOI   ScienceOn
5 Bani D, Maurizi M, Bigazzi M: Original article: relaxin reduces the number of circulating platelets and depresses platelet release from megakaryocytes: studies in rats. Platelets 6: 330, 1995   DOI   ScienceOn
6 Bani D, Bigazzi M, Masini E, Bani G, Sacchi TB: Relaxin depresses platelet aggregation: in vitro studies on isolated human and rabbit platelets. Lab Invest 73: 709, 1995
7 Zheng Y, Yi C, Xia W, Ding T, Zhou Z, Han Y, Guo S: Mesenchymal stem cells transduced by vascular endothelial growth factor gene for ischemic random skin flaps. Plast Reconstr Surg 121: 59, 2008   DOI   ScienceOn
8 Sherwood OD: Relaxin's physiological roles and other diverse actions. Endocr Rev 25: 205, 2004   DOI   ScienceOn
9 Unemori EN, Erikson ME, Rocco SE, Sutherland KM, Parsell DA, Mak J, Grove BH: Relaxin stimulates expression of vascular endothelial growth factor in normal human endometrial cells in vitro and is associated with meno-metrorrhagia in women. Hum Reprod 14: 800, 1999   DOI   ScienceOn
10 Samuel CS, Hewitson TD, Unemori EN, Tang ML: Drugs of the future: the hormone relaxin. Cell Mol Life Sci 64: 1539, 2007   DOI   ScienceOn
11 Hopper RA, Forrest CR, Xu H, Zhong A, He W, Rutka J, Neligan P, Pang CY: Role and mechanism of PKC in ischemic preconditioning of pig skeletal muscle against infarction. Am J Physiol Regul Integr Comp Physiol 279: R666, 2000   DOI
12 Kim JH, Lee YS, Kim H, Huang JH, Yoon AR, Yun CO: Relaxin expression from tumor-targeting adenoviruses and its intratumoral spread, apoptosis induction, and efficacy. J Natl Cancer Inst 98: 1482, 2006   DOI   ScienceOn
13 Khan A, Ashrafpour H, Huang N, Neligan PC, Kontos C, Zhong A, Forrest CR, Pang CY: Acute local subcutaneous VEGF165 injection for augmentation of skin flap viability: efficacy and mechanism. Am J Physiol Regul Integr Comp Physiol 287: R1219, 2004   DOI   ScienceOn
14 Kerrigan CL: Skin flap failure: pathophysiology. Plast Reconstr Surg 72: 766, 1983   DOI   ScienceOn
15 Maldonado C, Stadelmann WK, Ramirez S, Quan EE, Barker JH: Preconditioning of latissimus dorsi muscle flaps with monophosphoryl lipid a. Plast Reconstr Surg 111: 267, 2003   DOI   ScienceOn